158 related articles for article (PubMed ID: 22075848)
1. Prognostic significance of Tiam1 expression in papillary thyroid carcinoma.
Hsueh C; Lin JD; Yang CF; Chang YS; Chao TC; Sun JH; Wu IC; Tseng NM; Ueng SH
Virchows Arch; 2011 Dec; 459(6):587-93. PubMed ID: 22075848
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of T-lymphoma invasion and metastasis inducing factor 1 in squamous-cell carcinoma of the head and neck and its clinical significance.
Wang S; Li S; Yang X; Yang S; Liu S; Liu B; Liu J
Eur J Cancer; 2014 Jan; 50(2):379-87. PubMed ID: 24189000
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of Tiam1-Rac1 signaling in primary gallbladder carcinoma.
Du X; Wang S; Lu J; Wang Q; Song N; Yang T; Dong R; Zang L; Yang Y; Wu T; Wang C
Med Oncol; 2012 Sep; 29(3):1873-8. PubMed ID: 21853342
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of T lymphoma invasion and metastasis 1 predict renal cell carcinoma metastasis and overall patient survival.
Zhao L; Liu Y; Sun X; He M; Ding Y
J Cancer Res Clin Oncol; 2011 Mar; 137(3):393-8. PubMed ID: 20429013
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
[TBL] [Abstract][Full Text] [Related]
6. Lack of association of BRAF mutation with negative prognostic indicators in papillary thyroid carcinoma: the University of California, San Francisco, experience.
Gouveia C; Can NT; Bostrom A; Grenert JP; van Zante A; Orloff LA
JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1164-70. PubMed ID: 24030686
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of Tiam1 protein expression in head and neck squamous cell carcinoma: a retrospective study.
Yang H; Cai YC; Cao Y; Song M; An X; Xia Y; Wei J; Jiang WQ; Shi YX
Chin J Cancer; 2015 Sep; 34(12):614-21. PubMed ID: 26369827
[TBL] [Abstract][Full Text] [Related]
8. Biotinidase is a novel marker for papillary thyroid cancer aggressiveness.
So AK; Kaur J; Kak I; Assi J; MacMillan C; Ralhan R; Walfish PG
PLoS One; 2012; 7(7):e40956. PubMed ID: 22911723
[TBL] [Abstract][Full Text] [Related]
9. Correlations of HOTAIR expression with pathological stage, CT characteristics and prognosis of patients with papillary thyroid carcinoma.
Chen X; Jin J; Zheng L; Sheng Y; Sun J
J BUON; 2021; 26(1):259-265. PubMed ID: 33721460
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of Tiam1 and Rac1 correlates with poor prognosis in hepatocellular carcinoma.
Yang W; Lv S; Liu X; Liu H; Yang W; Hu F
Jpn J Clin Oncol; 2010 Nov; 40(11):1053-9. PubMed ID: 20522449
[TBL] [Abstract][Full Text] [Related]
11. Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter.
Hou X; Jiang L; Chen C; Zhu X; Ge M
Clin Lab; 2015; 61(7):793-9. PubMed ID: 26299079
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients.
Ding Y; Chen B; Wang S; Zhao L; Chen J; Ding Y; Chen L; Luo R
Int J Cancer; 2009 Feb; 124(3):653-8. PubMed ID: 18972435
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of T-lymphoma and metastasis gene 1 in gastric cancer and its involvement in cell invasion and migration.
Shi YL; Miao RZ; Cheng L; Guo XB; Yang B; Jing CQ; Zhang L; Jin X; Li LP
Chin Med J (Engl); 2013 Feb; 126(4):640-5. PubMed ID: 23422181
[TBL] [Abstract][Full Text] [Related]
14. Expression of Tiam1 in lung cancer and its clinical significance.
Wang HM; Wang J
Asian Pac J Cancer Prev; 2012; 13(2):613-5. PubMed ID: 22524833
[TBL] [Abstract][Full Text] [Related]
15. Combined analysis of Rac1, IQGAP1, Tiam1 and E-cadherin expression in gastric cancer.
Walch A; Seidl S; Hermannstädter C; Rauser S; Deplazes J; Langer R; von Weyhern CH; Sarbia M; Busch R; Feith M; Gillen S; Höfler H; Luber B
Mod Pathol; 2008 May; 21(5):544-52. PubMed ID: 18246045
[TBL] [Abstract][Full Text] [Related]
16. MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma.
Liu N; Tang LL; Sun Y; Cui RX; Wang HY; Huang BJ; He QM; Jiang W; Ma J
Cancer Lett; 2013 Feb; 329(2):181-8. PubMed ID: 23142282
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of RET/PTC expression in papillary thyroid carcinoma and its correlation with prognostic factors in a north Indian population.
Mishra A; Agrawal V; Krishnani N; Mishra SK
J Postgrad Med; 2009; 55(3):171-5. PubMed ID: 19884740
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Tiam1 is associated with malignant phenotypes of nasopharyngeal carcinoma.
Ding Y; Chen B; Huang J; Zhang W; Yang H; Deng Y; Lin J; Wang S; Zhang X
Oncol Rep; 2014 Aug; 32(2):607-18. PubMed ID: 24912585
[TBL] [Abstract][Full Text] [Related]
19. USP33 is a Biomarker of Disease Recurrence in Papillary Thyroid Carcinoma.
Jia M; Guo Y; Lu X
Cell Physiol Biochem; 2018; 45(5):2044-2053. PubMed ID: 29533940
[TBL] [Abstract][Full Text] [Related]
20. The guanine nucleotide exchange factor Tiam1: a Janus-faced molecule in cellular signaling.
Boissier P; Huynh-Do U
Cell Signal; 2014 Mar; 26(3):483-91. PubMed ID: 24308970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
